Effects of a 10% dimethyl sulfoxide solution on radiocarpal joint amikacin pharmacokinetics during intravenous regional limb perfusion in standing sedated horses
Veterinary Surgery · 2023
DOI: 10.1111/vsu.13973 ↗Kurz gefasst
Fachartikel in der Zeitschrift Veterinary Surgery, 2023. Verfasst von Isabelle Kilcoyne und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgical and Radiological Sciences, School of Veterinary Medicine, University of California, Los Angeles, California, USA. Hauptthemen laut MEDLINE: Amikacin, Anti-Bacterial Agents. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 39 Literaturangaben. Gefördert von: American Quarter Horse Foundation, American Quarter Horse Foundation..
Abstract (Originalsprache)
Objective
To determine the effect of a 10% dimethyl sulfoxide (DMSO) solution on the peak concentration (C MAX ) of amikacin in the radiocarpal joint (RCJ) during intravenous regional limb perfusion (IVRLP) compared with 0.9% NaCl. Study design Randomized crossover study. Animals Seven healthy adult horses.
Methods
The horses underwent IVRLP with 2 g of amikacin sulfate diluted to 60 mL using a 10% DMSO or 0.9% NaCl solution. Synovial fluid was collected from the RCJ at 5, 10, 15, 20, 25, and 30 minutes after IVRLP. The wide rubber tourniquet placed on the antebrachium was removed after the 30 min sample. Amikacin concentrations were quantified by a fluorescence polarization immunoassay. The mean C MAX and time to peak concentration (T MAX ) of amikacin within the RCJ were determined. A one‐sided paired t ‐test was used to determine the differences between treatments. The significance level was p < .05.
Results
The mean ± SD C MAX in the DMSO group was 1361.8 ± 593 μg/mL and in the 0.9% NaCl group it was 860 ± 481.6 μg/mL ( p = .058). Mean T MAX using the 10% DMSO solution was 23 and 18 min using the 0.9% NaCl perfusate ( p = .161). No adverse effects were associated with use of the 10% DMSO solution.
Conclusion
Although there were higher mean peak synovial concentrations using the 10% DMSO solution no difference in synovial amikacin C MAX between perfusate type was detected ( p = .058). Clinical significance Use of a 10% DMSO solution in conjunction with amikacin during IVRLP is a feasible technique and does not negatively affect the synovial amikacin levels achieved. Further research is warranted to determine other effects of using DMSO during IVRLP.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Surgical and Radiological Sciences, School of Veterinary Medicine, University of California, Los Angeles, California, USA.
- Department of Medicine and Epidemiology, School of Veterinary Medicine, University of California, Los Angeles, California, USA.
- Department of Clinical Sciences, College of Veterinary Medicine and Biomedical Sciences, Colorado State University, Fort Collins, Colorado, USA.
Förderung
- American Quarter Horse Foundation
- American Quarter Horse Foundation.
Zitieren
APA
Kilcoyne, I., Nieto, J., Magdesian, K. G., & Nottle, B. F. (2023). Effects of a 10% dimethyl sulfoxide solution on radiocarpal joint amikacin pharmacokinetics during intravenous regional limb perfusion in standing sedated horses. Veterinary Surgery. https://doi.org/10.1111/vsu.13973
Vancouver
Kilcoyne I, Nieto J, Magdesian KG, Nottle BF. Effects of a 10% dimethyl sulfoxide solution on radiocarpal joint amikacin pharmacokinetics during intravenous regional limb perfusion in standing sedated horses. Veterinary Surgery. 2023. doi:10.1111/vsu.13973
BibTeX
@article{Kilcoyne2023,
author = {Kilcoyne, Isabelle and Nieto, Jorge and Magdesian, K Gary and Nottle, Bridget F},
title = {Effects of a 10% dimethyl sulfoxide solution on radiocarpal joint amikacin pharmacokinetics during intravenous regional limb perfusion in standing sedated horses},
journal = {Veterinary Surgery},
year = {2023},
doi = {10.1111/vsu.13973}
}
EUVIMED